PharmaRoth Labs (PharmaRoth Labs) ROCE % : 0.00% (As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PharmaRoth Labs's annualized ROCE % for the quarter that ended in Mar. 2011 was 0.00%.

PharmaRoth Labs ROCE % Historical Data

The historical data trend for PharmaRoth Labs's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs ROCE % Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

ROCE %

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
ROCE %	Get a 7-Day Free Trial											-	-	-	-	-

PharmaRoth Labs ROCE % Calculation

PharmaRoth Labs's annualized ROCE % for the fiscal year that ended in Jun. 2010 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2010 )		(A: Jun. 2009 )		(A: Jun. 2010 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2010 )		(A: Jun. 2009 )		(A: Jun. 2010 )
	=	-0.02	/	( ( (0 - 0.01)	+	(0 - 0.006) )	/ 2 )
	=	-0.02	/	( (-0.01	+	-0.006)	/ 2 )
	=	-0.02	/	-0.008
	=	250.00 %

PharmaRoth Labs's ROCE % of for the quarter that ended in Mar. 2011 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2011 )		(Q: Dec. 2010 )		(Q: Mar. 2011 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2011 )		(Q: Dec. 2010 )		(Q: Mar. 2011 )
	=	-0.392	/	( ( (0.028 - 0.349)	+	(0.095 - 0.39) )	/ 2 )
	=	-0.392	/	( ( -0.321	+	-0.295 )	/ 2 )
	=	-0.392	/	-0.308
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2011) EBIT data.

PharmaRoth Labs (GREY:ROTH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PharmaRoth Labs ROCE % Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022